Every material Form 8-K Hawkins filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Hawkins, Inc. reported record second-quarter fiscal 2027 results, with sales up 12% to $313.8 million and diluted EPS up 23% to $1.34 for the quarter ended September 27, 2026. Gross profit rose 13% to $76.6 million, and the company's SG&A and tax rate rose modestly, but profit growth outpaced sales growth for shareholders. The company also said second-half trends should be consistent with the first half, while noting a non-recurring $6.2 million SG&A benefit in the prior-year second half will not recur.
Quarterly sales rose $33.4 million, or 12%, to $313.8 million; Water Treatment sales grew 16% to $175.0 million.
Diluted EPS was $1.34, up $0.25 from $1.08 a year earlier; net income rose 23% to $27.8 million.
Total debt fell to $229.0 million; leverage ratio was 1.22x adjusted EBITDA, down from 1.37x at fiscal 2026 year-end.
Hawkins repurchased $18.6 million of stock in the six months and closed the Dave Symonds & Associates acquisition; Eagle Labs was acquired after quarter end.
Hawkins, Inc. said director Yi "Faith" Tang resigned from its Board of Directors and all board committees, effective immediately, after notifying the company on August 13, 2026. The filing states her resignation was not due to any disagreement with the company on its operations, policies or practices.
Yi "Faith" Tang resigned from the Board of Directors and its committees.
Notice was given on August 13, 2026; the resignation is effective immediately.
The filing states there was no disagreement relating to company operations, policies or practices.
Hawkins reported fiscal 2027 first-quarter results for the three months ended June 28, 2026. Sales rose 8% to $315.7 million, a record for the quarter, but net income fell 3% to $28.3 million and diluted EPS fell $0.05 to $1.35, as higher LIFO reserve and freight costs and lower gross margin offset the sales gain. Shareholders see growth in revenue alongside lower profit per share, and the company did not change any guidance in this filing.
Revenue of $315.7 million, up 8% from $293.3 million; all three segments grew more than 5%.
Net income of $28.3 million, down 3%, or $1.35 per diluted share versus $1.40 a year earlier.
Gross profit rose 2% to $74.0 million, but gross margin fell to 23% of sales from 25%.
Adjusted EBITDA, a non-GAAP measure, rose 1% to $56.9 million; the company repurchased $7.0 million of stock and paid $4.0 million in dividends.
Hawkins, Inc. said Shirley A. Rozeboom, Vice President – Stauber, was determined on May 13, 2026 to no longer be an executive officer, effective that day. The company said the change is part of a planned transition tied to a segment reporting realignment, and that Ms. Rozeboom remains employed by the company.
Shirley A. Rozeboom, Vice President – Stauber, no longer designated an executive officer as of May 13, 2026
Change is part of a planned transition linked to realignment of reporting segments, first effective for the fiscal year ended March 29, 2026
Hawkins reported fiscal 2026 sales of $1.08 billion, up 11%, but diluted earnings per share fell 3% to $3.91 and net income fell to $81.5 million from $84.3 million. The company attributed the profit decline mainly to about $16.5 million in higher amortization, interest expense and earnout-related fair value accretion from six acquisitions, and said pro forma EPS would have risen 9%. Management expects fiscal 2027 EPS to grow.
Fourth-quarter sales were $265.9 million, up 8%, while fourth-quarter diluted EPS was $0.74 versus $0.78 a year earlier.
Full-year adjusted EBITDA was $179.0 million, up 6%, and operating cash flow was $144.3 million, up 30%.
Total debt was $244.0 million at fiscal year-end, and the leverage ratio rose to 1.37x from 0.86x.
For fiscal 2027, management expects EPS to grow and an income tax rate of 25% to 27%.
Hawkins, Inc. reported fiscal 2026 third-quarter results for the period ended December 28, 2025. Sales rose 8% to $244.1 million and adjusted EBITDA rose 3% to $34.8 million, but diluted EPS fell to $0.69 from $0.72, which the company attributed mainly to about $5 million of higher amortization and interest expense from its acquisitions.
Sales were $244.1 million, up $17.9 million or 8% from a year earlier, with Water Treatment up 21% and Industrial Solutions up 10%.
Food & Health Sciences sales fell 10% to $70.0 million.
Net income was $14.3 million, or $0.69 per diluted share, versus $15.0 million, or $0.72, a year earlier.
Total debt was $264.0 million at quarter end, and the leverage ratio was 1.47x trailing 12-month adjusted EBITDA.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Hawkins filing is on SEC EDGAR ↗. 8-K briefs of other companies →